Maribao, Allan V.

HRN: 21-02-54  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/13/2026
CEFTAZIDIME 1GM (VIAL)
03/13/2026
03/19/2026
IV
2gm
Q8
Intraabdominal Infection
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: